|
|
Volumn 2, Issue 2, 2002, Pages 47-51
|
|
Giving informed consent on hormone replacement therapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALENDRONIC ACID;
ANTIHYPERTENSIVE AGENT;
ESTROGEN DERIVATIVE;
FLUOXETINE;
GINKGO BILOBA EXTRACT;
IPRIFLAVONE;
PAROXETINE;
PHYTOESTROGEN;
PRIMROSE OIL;
PROGESTERONE DERIVATIVE;
RALOXIFENE;
RISEDRONIC ACID;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
SOYBEAN PROTEIN;
TAMOXIFEN;
TIBOLONE;
VENLAFAXINE;
BLEEDING DISORDER;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR DISEASE;
COMPREHENSION;
CONTROLLED STUDY;
DEMENTIA;
DOCTOR PATIENT RELATION;
DRUG EFFICACY;
EDITORIAL;
FEMALE;
GENERAL PRACTITIONER;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
INFORMED CONSENT;
MEDICAL INFORMATION;
METHODOLOGY;
OSTEOPOROSIS;
PATIENT EDUCATION;
RISK BENEFIT ANALYSIS;
|
|
EID: 0036595010
PISSN: 15270289
EISSN: None
Source Type: Journal
DOI: 10.1053/cjwh.2002.127858 Document Type: Editorial |
|
Times cited : (1)
|
|
References (2)
|
